Printer Friendly

COMPANY INFORMATION
Nymox Pharmaceutical Corporation 306-9900 boul Cavendish Saint-Laurent, QC H4M 2V2 Tel: (514) 332-3222 Toll-free: (800) 936-9669 Fax: (514) 332-2227 Contact Name Roy M. Wolvin Industry Pharmaceuticals		Key Executives Paul Averback, CEO Roy M. Wolvin, CFO Researches and develops products for the diagnosis and treatment of Alzheimer's disease, brain disorders, tobacco product use and exposure, bacterial infections and prostatic hyperplasia.
FP ADVISOR COVERAGE Nymox Pharmaceutical Corporation • FP Corporate Surveys • FP Predecessor & Defunct • Ordering FP Products		TOP INDUSTRY PLAYERS Pharmaceuticals Company Name Revenue ($000s)  Biovail Corporation 936,111 Patheon Inc. 765,812 Cangene Corporation 238,751 Paladin Labs Inc. 109,693 Cardiome Pharma Corp. 54,672 (Links are to Snapshots.)
ANNUAL FINANCIALS Periods ended: 12m Dec. 31/09 12m Dec. 31/08 12m Dec. 31/07 US$000s US$000s US$000s Operating revenue 416 427 413 Net income (5,130) (4,590) (5,290) Total assets 1,090 4,068 4,260 US$ US$ US$ Earnings per share* (0.17) (0.15) (0.18) % % % Return on equity n.m. (219.77) (331.35)   * Common

COMPANY NEWS

Results for 'Nymox Pharmaceutical Corporation' from past 30 days: No hits. (Links are to articles.)